- Home
- LFCR vs LTBR Comparison
LFCR vs LTBR Comparison
Compare LFCR & LTBR Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- LFCR
- LTBR
- Stock Information
- Founded
- LFCR 1986
- LTBR 1992
- Country
- LFCR United States
- LTBR United States
- Employees
- LFCR N/A
- LTBR N/A
- Industry
- LFCR Biotechnology: Pharmaceutical Preparations
- LTBR Professional Services
- Sector
- LFCR Health Care
- LTBR Consumer Discretionary
- Exchange
- LFCR Nasdaq
- LTBR Nasdaq
- Market Cap
- LFCR 308.8M
- LTBR 397.8M
- IPO Year
- LFCR N/A
- LTBR N/A
- Fundamental
- Price
- LFCR $7.61
- LTBR $15.13
- Analyst Decision
- LFCR Buy
- LTBR
- Analyst Count
- LFCR 4
- LTBR 0
- Target Price
- LFCR $8.00
- LTBR N/A
- AVG Volume (30 Days)
- LFCR 108.3K
- LTBR 1.5M
- Earning Date
- LFCR 08-07-2025
- LTBR 08-11-2025
- Dividend Yield
- LFCR N/A
- LTBR N/A
- EPS Growth
- LFCR N/A
- LTBR N/A
- EPS
- LFCR N/A
- LTBR N/A
- Revenue
- LFCR $128,867,000.00
- LTBR N/A
- Revenue This Year
- LFCR $4.78
- LTBR N/A
- Revenue Next Year
- LFCR $12.02
- LTBR N/A
- P/E Ratio
- LFCR N/A
- LTBR N/A
- Revenue Growth
- LFCR 0.47
- LTBR N/A
- 52 Week Low
- LFCR $3.68
- LTBR $2.24
- 52 Week High
- LFCR $8.85
- LTBR $18.80
- Technical
- Relative Strength Index (RSI)
- LFCR 53.94
- LTBR 52.17
- Support Level
- LFCR $7.33
- LTBR $12.93
- Resistance Level
- LFCR $7.73
- LTBR $16.19
- Average True Range (ATR)
- LFCR 0.30
- LTBR 1.48
- MACD
- LFCR 0.03
- LTBR -0.02
- Stochastic Oscillator
- LFCR 65.33
- LTBR 37.48
About LFCR Lifecore Biomedical Inc.
Lifecore Biomedical Inc is a fully integrated contract development and manufacturing organization (CDMO) that offers differentiated capabilities in the development, filling, and finishing of complex sterile injectable pharmaceutical products in syringes and vials. It manufactures injectable-grade Hyaluronic Acid. Lifecore recognizes revenue in two different product categories, CDMO and fermentation.
About LTBR Lightbridge Corporation
Lightbridge Corp is a United States-based nuclear fuel technology company. The business activity of the firm is functioned through one business segment, which is the development and commercialization of its nuclear fuel. The Nuclear Fuel Technology segment develops next generation nuclear fuel technology that increases the power output of commercial reactors and reduces the cost of generating electricity. Geographically, its operations are functioned through the region of Unites States.